期刊文献+

雌激素受体(ER)与基因蛋白(P53、erbB-2)在胃癌中表达的研究

The study of expression of ER \ P53 and erbB - 2 in gastric carcinoma
下载PDF
导出
摘要 目的:探讨ER、erbB-2和P53在胃癌表达及相关性。方法:取胃癌手术标本119例,SP免疫组织化学染色。结果:ER、erbB-2和P53在胃癌表达率分别为63.87%,75.51%和73.11%;三者同时阳性者31.93%;ER与P53同时阳性者37.82%;ER与erbB-2同时阳性者33.61%;ER在高分化组阳性率高于低分化组(P<0.05);而erbB-2和P53在低分化组阳性率高于高分化组。70岁以上组P53、ER和erbB-2表达率均较高。结论:ER、P53和erbB-2在胃癌中表达率与癌瘤分化程度相关。P53和erbB-2有相关性,而且它们是胃癌预后不良的指标。 Objective: To study expression and correlation of ER. . P53 and erbB - 2 in gastric carcinoma. Methods: 119 cases of gastric cancer was examined using paraggin section and SP immunohistochemical staine. Results: The positive rat of ER.P53 and erbB-2 of gastric crcino-ma were 64.71%. 73.11% and 65.55% ;The three items concurrented positive were 31.93% of all; The positive of erbB - 2 and ER were concurreted 33.61 % ; The positive of ER and P53 were concurrete 37.82 % ;The positive P53 and erbB - 2 were concurrete 45.38 % . The positive rat of ER in high differentiation concer were higher than low differentiation group (P<0.05) . But the positive rat of erbB - 2 and p53 in low differentation group were higher than other group ( P < 0. 05 ). Conclusion:The obvious correlation was gound between the expression of ER. P53 and erbB - 2 with differentiation degree of cancer . The p53 and erbB - 2 have closely relative. They was target of harmful prognosis.
出处 《张家口医学院学报》 2001年第5期1-3,共3页
关键词 ERBB-2 ER 胃癌手术 阳性 表达率 基因蛋白 雌激素受体 高分 结论 目的 Gastric carcinoma Gene protein Estrogen receptor( ER) immunohistoche-mistry
  • 相关文献

参考文献12

二级参考文献43

  • 1任力强.抗癌基因p53与癌基因mdm2[J].生命的化学,1994,14(2):20-21. 被引量:9
  • 2卫生部医政司.中国常见恶性肿瘤诊治规范(乳腺)[M].北京:北京医科大学与中国协和医科大学联合出版社,1991.53-56.
  • 3BloomHJG,RichardsonWW.Histologicalgradingandprognosisinbreastcancer[J].BrJCancer,1957,11(3):359-377.
  • 4SlamonDJ,GodolphinW,JonesLA,etal.StudiesoftheHER-2/neuproto-oncogeneinhumanbreastandovariancancer[J].Science,1989,244(4905):707-712.
  • 5WrightC,AngusB,NicholosonS,etal.Expressionofc-erbB-2oncoprotein:aprognosticindictorinhumanbreastcancer[J].CancerRes,1989,49(8):2087-2090.
  • 6SerranoM,HannonGJ,BeachD.Anewregulatorymotifincell-cyclecontrolcausingspecificinhibitionofcyclinD/CDK4[J].Nature,1993,366(6456):704-707.
  • 7RanadeK,HussussianCJ,SikorskiRS,etal.Mutationsassociatedwithfamilialmelanomaimpairp16function[J].NatureGenet,1995,10(1):114-116.
  • 8LoKW,CheungS,TLeungSF,etal.Hypermethylationofthep16geneinnasopharyngealcarcinoma[J].CancerRes,1996,56(12):2721-2725.
  • 9TamSW,ShayJW,PaganoM.Differentialexpressionandcellcycleregulationofthecyclin-dependentkinase4inhibitorp16INK4[J].CancerRes,1994,54(22):5816-5820.
  • 10BartkovaJ,LuksJ,MullerH,etal.CyclinD1proteinexpressionandfunctioninhumanbreastcancer[J].IntJCancer,1994,57(3):353-361.

共引文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部